Sunshine heart management have to change the way cardiologists treat heat failure , that is not an easy task , C-Pulse is creating its own new market all for itself treating less sick patients upstream than class 4, that is what is taking time , there is no other treatment that shows class improvement the way C-Pulse has shown , as patient data is released good things will follow, good luck investors .
SHC Price at posting:
2.5¢ Sentiment: Buy Disclosure: Held